Enhancing Uptake of Preconception Care Services in Family Practice Clinics Using a Patient Centered Screening Tool
1 other identifier
interventional
286
1 country
1
Brief Summary
Sixteen years have passed since the Centers for Disease Control recommended routine preconception screening and counseling in primary care settings, yet time constraints and low preconception counseling adherence have prevented widespread uptake. This innovative, self-selected preconception screening tool encourages participants to be active in their own care and eliminates the time burden associated with typical pre-selected screening in clinics. This project will generate important knowledge about the promise of utilizing a participant-selected preconception screening tool to promote preconception health behavior change during routine medical encounters for women of reproductive age.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Sep 2023
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 23, 2023
CompletedFirst Submitted
Initial submission to the registry
August 26, 2024
CompletedFirst Posted
Study publicly available on registry
September 3, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 26, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
August 26, 2025
CompletedDecember 24, 2025
December 1, 2025
1.9 years
August 26, 2024
December 22, 2025
Conditions
Outcome Measures
Primary Outcomes (5)
Risk Detection Rate
Percentage of participants identified as having at least one preconception risk factor. Risk rate will be compared between the two types of screen tool (Group 1 - Short Form/Patient Centered and Group 2 - Long Form/Risk Based). Risk detection rates between the two screening methods will be compared against the benchmark risk as assessed in the post-visit questionnaire.
18 month duration of study
Screening Tool Completion Rate
Rate of completion for each screening tool. Percent of participants with 75% completion of the screening tool will be compared across Group 1 (Short Form/Patient Centered) and Group 2 (Long Form/Risk Based).
18 month duration of study
Health Care Relationship Trust Scale - Revised
Participants trust in their health care provider will be measured using the Health Care Relationship Trust Scale - Revised (HCR Trust Scale-R). HCR Trust Scale-R scores range from 0 to 52, which higher scores indicating greater levels of trust. The instrument will be administered in the post-visit questionnaire. Trust scores will be compared across intervention arms and against the control group.
18 month duration of the study
Preconception Health Behavior Intentions
Intention to change health behavior and self-efficacy for change in response to identified health risks. Measured in the post-visit questionnaire, through the Patient Enablement Instrument (PEI). PEI scores range from 0 to 12, which higher scores indicating greater levels of patient enablement. Additionally, the research team developed two survey items. One item asks respondents if they have the knowledge and skills to improve their preconception health. Response options are yes or no. The second item asks how confident respondents feel that they will make at least one preconception health change. Response options follow Likert scale (1-4) ranging from \"Not at all confident\" to \"Extremely confident.\" Comparisons in preconception health behavior intention will be compared between both intervention arms, and against the control group.
18 month duration of the study
Preconception Knowledge
Awareness of basic preconception health care was assessed through the post-visit questionnaire. To assess knowledge, participants read the following statement: \"The following are a set of statements about health and pregnancy. Please answer whether you agree, disagree or are unsure about these statements.\" This was followed by a series of statements about preconception health such as: \"Folic acid should be taken before pregnancy;\" \"A person\'s weight when they become pregnant can affect the pregnancy; and \"Certain health conditions, like diabetes and hypertension can increase the chances of pregnancy complications.\" Possible responses were "Agree," "Disagree," or "Unsure." Scores range from 0 to 10, with higher scores indicated higher knowledge. Preconception awareness will be compared across the two intervention groups and against the control group.
18 month duration of the study
Study Arms (3)
Patient-centered Pre-conception Screening
EXPERIMENTALA short form, 2 question screening form which asks participants which preconception health topics they would like to discuss with their doctor today. Includes an option for "None of these. I would not like to discuss how my health can affect fertility and any future pregnancies"
Risk-based Pre-conception Screening
ACTIVE COMPARATORA long form questionnaire screening for a range of preconception health risk factors including: age, weight, exercise, diet, nutrition, health conditions, risky behaviors, immunization status, prescription medications, birth control use
Control
NO INTERVENTIONParticipant is asked a single question: "Your health today can make a difference for the pregnancy you experience tomorrow. Do you agree with the statement above?"
Interventions
A long form questionnaire screening questionnaire administered via tablet in health clinic waiting room. Offered to participants when checking-in for appointment.
A short form, 2 question screening administered via tablet in health clinic waiting room. Offered to participants when checking-in for appointment.
Eligibility Criteria
You may qualify if:
- Biologically female
- Child-bearing age
- Visiting the clinic for a routine or preventative appointment during the study period
You may not qualify if:
- Under 19 or over 49 years of age
- Not biologically female
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Nebraska Medicine - Fontenelle Clinic
Omaha, Nebraska, 68104, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Shannon I Maloney, PhD
University of Nebraska
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 26, 2024
First Posted
September 3, 2024
Study Start
September 23, 2023
Primary Completion
August 26, 2025
Study Completion
August 26, 2025
Last Updated
December 24, 2025
Record last verified: 2025-12
Data Sharing
- IPD Sharing
- Will not share